Compound ID | 391
Sulopenem
Class: Beta-lactam (penem)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Potent spectrum of activity against multi-drug resistant gram-negative infections in both the hospital and community settings |
| Description: | Noshino T, Otsuki M and Komoto A. In vitro and in vivoantibacterial activities of CP-70429, a novel penem. 32nd-Intersci-Conf-Antimicrobial-Agents-Chemother 1992; 176 |
| Institute where first reported: | Iterum Therapeutics Ltd. |
| Year first mentioned: | 1980 |
| Highest developmental phase: | Phase 3 |
| Development status: | Active |
| External links: | |
| Guide to Pharmacology: | sulopenem |
| Main Source: | https://www.iterumtx.com/our-science/our-promise |
| Citation: | https://aac.asm.org/content/53/6/2239 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us.
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.